Amino cyclobutylamide modulators of chemokine receptor activity

Details for Australian Patent Application No. 2004222336 (hide)

International Classifications

Event Publications

29 September 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Merck & Co. Inc. to Merck & Co., Inc.

29 September 2005 PCT application entered the National Phase

PCT publication WO2004/082682 Priority application(s): WO2004/082682

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

3 June 2010 Application Accepted

Published as AU-B-2004222336

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.